Terrie Curran Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Terrie Curran.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Terrie Curran. Terrie Curran is a in CELGENE CORP /DE/ ($CELG) and a PRES., GLBL INFLAM. AND IMMUN. in CELGENE CORP /DE/ ($CELG) and a See remarks in CELGENE CORP /DE/ ($CELG) and a Director in Myovant Sciences Ltd. ($MYOV) and an President and Chief Executive in Phathom Pharmaceuticals, Inc. ($PHAT) and a Director in Arcutis Biotherapeutics, Inc. ($ARQT).
Address: C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK 10018 NY
Companies in which Terrie Curran is an Insider
Arcutis Biotherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Terrie Curran: Director
Holdings: 0 shares
Latest Transaction: Nov 04 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CELGENE CORP /DE/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Terrie Curran: PRES., GLBL INFLAM. AND IMMUN., SEE REMARKS
Holdings: 9,452 shares
Current Value: $1,098,890
Latest Transaction: Nov 22 2019
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Myovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Terrie Curran: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 17 2020
$MYOV Market Capitalization: $630.81M
$MYOV Previous Close: $10.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Phathom Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Terrie Curran: President and Chief Executive
Holdings: 11,513 shares
Latest Transaction: Mar 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Terrie Curran
Sentiment: All, ARQT, CELG, MYOV, PHAT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Option Exercise | M | 6.95 | 11,513 | 80,015 | 855,687 | |
| Mar 23 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Sell | S | 44.08 | 1,140 | 50,256 | 0 | 1.1 K to 0 (-100.00 %) |
| Mar 23 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Sell | S | 43.24 | 10,373 | 448,495 | 1,140 | 11.5 K to 1.1 K (-90.10 %) |
| Mar 23 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Buy | M | 6.95 | 11,513 | 80,015 | 11,513 | 0 to 11.5 K |
| Jan 29 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Option Exercise | A | 39.11 | 225,000 | 8,799,750 | 225,000 | |
| Nov 04 2020 | ARQT | Arcutis Biotherape ... | Curran Terrie | Director | Option Exercise | A | 18.72 | 37,500 | 702,000 | 37,500 | |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | Curran Terrie | Director | Option Exercise | A | 21.47 | 21,603 | 463,816 | 21,603 |